MedPath

IP3R Modulation by Cancer Genes in Mesothelioma

Conditions
Malignant Mesothelioma
Registration Number
NCT03558932
Lead Sponsor
KU Leuven
Brief Summary

Obtaining pleural biopsies in cases of malignant mesothelioma to detect molecular mechnisms and signal transduction

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • suspicion of mesothelioma
  • referral for diagnostic thoracoscopy
Exclusion Criteria
  • contra-indication for thoracoscopy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pleural biopsy5 years

Biopsy

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath